These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11703851)

  • 1. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
    Winstanley P
    Trop Med Int Health; 2001 Nov; 6(11):952-4. PubMed ID: 11703851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.
    Wootton DG; Opara H; Biagini GA; Kanjala MK; Duparc S; Kirby PL; Woessner M; Neate C; Nyirenda M; Blencowe H; Dube-Mbeye Q; Kanyok T; Ward S; Molyneux M; Dunyo S; Winstanley PA
    PLoS One; 2008 Mar; 3(3):e1779. PubMed ID: 18320064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of Lapdap, an affordable new treatment for malaria.
    Lang T; Greenwood B
    Lancet Infect Dis; 2003 Mar; 3(3):162-8. PubMed ID: 12614733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
    Amukoye E; Winstanley PA; Watkins WM; Snow RW; Hatcher J; Mosobo M; Ngumbao E; Lowe B; Ton M; Minyiri G; Marsh K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2261-4. PubMed ID: 9333058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
    Tiono AB; Dicko A; Ndububa DA; Agbenyega T; Pitmang S; Awobusuyi J; Pamba A; Duparc S; Goh LE; Harrell E; Carter N; Ward SA; Greenwood B; Winstanley PA
    Am J Trop Med Hyg; 2009 Dec; 81(6):969-78. PubMed ID: 19996424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.
    Luzzatto L
    Lancet; 2010 Aug; 376(9742):739-41. PubMed ID: 20599264
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
    Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
    Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania.
    Mutabingwa TK; Maxwell CA; Sia IG; Msuya FH; Mkongewa S; Vannithone S; Curtis J; Curtis CF
    Trans R Soc Trop Med Hyg; 2001; 95(4):433-8. PubMed ID: 11579891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
    Stewart LB; Peters W; Robinson BL
    Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
    Van Malderen C; Van Geertruyden JP; Machevo S; González R; Bassat Q; Talisuna A; Yeka A; Nabasumba C; Piola P; Daniel A; Turyakira E; Forret P; Van Overmeir C; van Loen H; Robert A; D' Alessandro U
    Malar J; 2012 Jul; 11():139. PubMed ID: 22546009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
    Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
    Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorproguanil-dapsone for treating uncomplicated malaria.
    Bukirwa H; Garner P; Critchley J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004387. PubMed ID: 15495106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
    Winstanley P; Watkins W; Muhia D; Szwandt S; Amukoye E; Marsh K
    Trans R Soc Trop Med Hyg; 1997; 91(3):322-7. PubMed ID: 9231209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
    Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
    Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.
    Trigg JK; Mbwana H; Chambo O; Hills E; Watkins W; Curtis CF
    Acta Trop; 1997 Feb; 63(2-3):185-9. PubMed ID: 9088432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.